Skip to main navigation Skip to search Skip to main content

Africa-specific human genetic variation near CHD1L associates with HIV-1 load

  • Paul J. McLaren*
  • , Immacolata Porreca
  • , Gennaro Iaconis
  • , Hoi Ping Mok
  • , Subhankar Mukhopadhyay
  • , Emre Karakoc
  • , Sara Cristinelli
  • , Cristina Pomilla
  • , István Bartha
  • , Christian W. Thorball
  • , Riley H. Tough
  • , Paolo Angelino
  • , Cher S. Kiar
  • , Tommy Carstensen
  • , Segun Fatumo
  • , Tarryn Porter
  • , Isobel Jarvis
  • , William C. Skarnes
  • , Andrew Bassett
  • , Marianne K. DeGorter
  • Mohana Prasad Sathya Moorthy, Jeffrey F. Tuff, Eun-Young Kim, Miriam Walter, Lacy M. Simons, Arman Bashirova, Susan Buchbinder, Mary Carrington, Andrea Cossarizza, Andrea de Luca, James J. Goedert, David B. Goldstein, David W. Haas, Joshua T. Herbeck, Eric O. Johnson, Pontiano Kaleebu, William Kilembe, Gregory D. Kirk, Neeltje A. Kootstra, Alex H. Kral, Olivier Lambotte, Ma Luo, Simon Mallal, Javier Martinez-Picado, Laurence Meyer, José M. Miro, Pravi Moodley, Ayesha A. Motala, James I. Mullins, Kireem Nam, Niels Obel, Fraser Pirie, Francis A. Plummer, Guido Poli, Matthew A. Price, Andri Rauch, Ioannis Theodorou, Alexandra Trkola, Bruce D. Walker, Cheryl A. Winkler, Jean-François Zagury, Stephen B. Montgomery, Angela Ciuffi, Judd F. Hultquist, Steven M. Wolinsky, Gordon Dougan, Andrew M. L. Lever, Deepti Gurdasani, Harriet Groom, Manjinder S. Sandhu*, Jacques Fellay*
*Corresponding author for this work
  • Public Health Agency of Canada
  • University of Manitoba
  • Wellcome Sanger Institute
  • University of Cambridge
  • St Thomas’ Hospital and King’s College London School of Medicine, London, UK
  • University of Lausanne
  • Swiss Federal Institute of Technology Lausanne
  • Swiss Institute of Bioinformatics
  • MRC/UVRI and LSHTM Uganda Research Unit
  • London School of Hygiene and Tropical Medicine
  • Jackson Laboratory
  • Stanford University
  • Northwestern University
  • National Institutes of Health
  • San Francisco Department of Public Health
  • Massachusetts Institute of Technology
  • University of Modena and Reggio Emilia
  • Azienda Ospedaliera Universitaria Senese
  • University of Siena
  • Columbia University
  • Vanderbilt University
  • University of Washington
  • RTI International
  • Center for Family Health Research in Zambia
  • Johns Hopkins University
  • Université Paris-Saclay
  • Assistance publique – Hôpitaux de Paris
  • Murdoch University
  • The University of Vic - Central University of Catalonia
  • IrsiCaixa AIDS Research Institute
  • ICREA
  • Centro de Investigación Biomédica en Red
  • Université Paris-Sud
  • University of Barcelona
  • University of KwaZulu-Natal
  • University of Copenhagen
  • Viral Evolution and Transmission Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy
  • Vita-Salute San Raffaele University
  • International AIDS Vaccine Initiative Neutralizing Antibody Center, United States
  • University of California at San Francisco
  • University of Bern
  • Hôpital Robert Debré AP-HP
  • Universität Zürich
  • Howard Hughes Medical Institute
  • Conservatoire national des arts et métiers
  • National University of Singapore
  • Queen Mary University of London
  • University of New South Wales
  • Imperial College London
  • MRC Centre for Environment and Health
  • Omnigen Biodata Ltd

Research output: Contribution to journalArticleAcademicpeer-review

31 Downloads (Pure)

Abstract

HIV-1 remains a global health crisis1, highlighting the need to identify new targets for therapies. Here, given the disproportionate HIV-1 burden and marked human genome diversity in Africa2, we assessed the genetic determinants of control of set-point viral load in 3,879 people of African ancestries living with HIV-1 participating in the international collaboration for the genomics of HIV3. We identify a previously undescribed association signal on chromosome 1 where the peak variant associates with an approximately 0.3 log10-transformed copies per ml lower set-point viral load per minor allele copy and is specific to populations of African descent. The top associated variant is intergenic and lies between a long intergenic non-coding RNA (LINC00624) and the coding gene CHD1L, which encodes a helicase that is involved in DNA repair4. Infection assays in iPS cell-derived macrophages and other immortalized cell lines showed increased HIV-1 replication in CHD1L-knockdown and CHD1L-knockout cells. We provide evidence from population genetic studies that Africa-specific genetic variation near CHD1L associates with HIV replication in vivo. Although experimental studies suggest that CHD1L is able to limit HIV infection in some cell types in vitro, further investigation is required to understand the mechanisms underlying our observations, including any potential indirect effects of CHD1L on HIV spread in vivo that our cell-based assays cannot recapitulate.
Original languageEnglish
Pages (from-to)1025-1030
Number of pages6
JournalNature
Volume620
Issue number7976
Early online date2023
DOIs
Publication statusPublished - 31 Aug 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 17 - Partnerships for the Goals
    SDG 17 Partnerships for the Goals

Fingerprint

Dive into the research topics of 'Africa-specific human genetic variation near CHD1L associates with HIV-1 load'. Together they form a unique fingerprint.

Cite this